SCHEMBL10288933

SCHEMBL10288933

Cc1ccccc1-c1nnc2cc(Cl)ccn12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
HSD17B10 Q99714 2/20 0.46
KMT2A Q03164 1/20 0.46
PDE2A O00408 1/20 0.45
PDE10A Q9Y233 1/20 0.45
MAPK13 O15264 2/20 0.43
CLK4 Q9HAZ1 2/20 0.41
FLT1 P17948 1/20 0.41
CDK8 P49336 1/20 0.41
CDK9 P50750 1/20 0.41
LIMK1 P53667 1/20 0.41
ROCK1 Q13464 1/20 0.41
ABL1 P00519 1/20 0.41
PDGFRA P16234 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CDK7 P50613 1/20 0.41
BTK Q06187 1/20 0.41
MAP4K2 Q12851 1/20 0.41
AURKB Q96GD4 1/20 0.41
DYRK1B Q9Y463 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379822 0.86 HSD11B1 (0.50) KDM4EHSD17B10KMT2APDE2APDE10A
SCHEMBL379692 0.83 HSD11B1 (0.52) KDM4EHSD17B10KMT2APDE2APDE10A
SCHEMBL13385743 0.75 HSD11B1 (0.53) KDM4EPDE2APDE10AMAPK13HSD11B1
SCHEMBL2021978 0.73 FLT1 (0.45) KDM4EHSD17B10KMT2APDE2APDE10A
SCHEMBL10288932 0.71 HSD11B1 (0.47) KDM4EHSD17B10KMT2AMAPK13CLK4
SCHEMBL3623290 0.71 HSD11B1 (0.47) KDM4EHSD17B10KMT2APDE2APDE10A
SCHEMBL379749 0.71 HSD11B1 (0.48) KDM4EHSD17B10KMT2APDE2APDE10A
SCHEMBL3277411 0.70 MAPK13 (0.47) KMT2AMAPK13MAP4K2
SCHEMBL2747248 0.69 HSD11B1 (0.78) PDE2APDE10AHSD11B1LMNAGAA
SCHEMBL10288930 0.69 DNMT1 (0.49) KDM4EHSD17B10PDE2APDE10AMAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2086973-B1 IMIDAZO- AND TRIAZOLO-PYRIDINE COMPOUNDS AND METHODS OF USE THEROF AMGEN INC (US) 2012-01-25 EP disclosed